Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Acid-coated Textiles (pH 5.5-6.5)--a New Therapeutic Strategy for Atopic Eczema?

Jaeger T, Rothmaier M, Zander H, Ring J, Gutermuth J, Anliker MD.

Acta Derm Venereol. 2015 Jun 24;95(6):659-63. doi: 10.2340/00015555-1916.

2.

Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?

Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki JR, Bockhorn M.

Stem Cells. 2014 Jun;32(6):1429-36. doi: 10.1002/stem.1665.

3.

CXCR7 expression in esophageal cancer.

Tachezy M, Zander H, Gebauer F, von Loga K, Pantel K, Izbicki JR, Bockhorn M.

J Transl Med. 2013 Sep 30;11:238. doi: 10.1186/1479-5876-11-238.

4.

ALCAM (CD166) expression and serum levels in pancreatic cancer.

Tachezy M, Zander H, Marx AH, Stahl PR, Gebauer F, Izbicki JR, Bockhorn M.

PLoS One. 2012;7(6):e39018. doi: 10.1371/journal.pone.0039018. Epub 2012 Jun 20.

5.

Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

Witzel I, Schröder C, Müller V, Zander H, Tachezy M, Ihnen M, Jänicke F, Milde-Langosch K.

Oncology. 2012;82(6):305-12. doi: 10.1159/000337222. Epub 2012 May 3.

PMID:
22555284
6.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.

Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, Izbicki JR, Bockhorn M.

J Surg Res. 2012 Sep;177(1):e15-20. doi: 10.1016/j.jss.2012.02.013. Epub 2012 Mar 30.

PMID:
22482754
7.

Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

Ihnen M, Kress K, Kersten JF, Kilic E, Choschzick M, Zander H, Müller V, Mahner S, Jänicke F, Woelber L, Milde-Langosch K.

BMC Cancer. 2012 Apr 4;12:140. doi: 10.1186/1471-2407-12-140.

8.

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.

Tachezy M, Effenberger K, Zander H, Minner S, Gebauer F, Vashist YK, Sauter G, Pantel K, Izbicki JR, Bockhorn M.

Int J Cancer. 2012 Jul 15;131(2):396-405. doi: 10.1002/ijc.26377. Epub 2011 Oct 20.

PMID:
21858815
9.

ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

Tachezy M, Zander H, Marx AH, Gebauer F, Rawnaq T, Kaifi JT, Sauter G, Izbicki JR, Bockhorn M.

J Surg Res. 2011 Oct;170(2):226-32. doi: 10.1016/j.jss.2011.06.002. Epub 2011 Jul 2.

PMID:
21816425
10.

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.

Güngör C, Zander H, Effenberger KE, Vashist YK, Kalinina T, Izbicki JR, Yekebas E, Bockhorn M.

Cancer Res. 2011 Jul 15;71(14):5009-19. doi: 10.1158/0008-5472.CAN-11-0036. Epub 2011 Jun 1.

11.

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.

Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki JR, Kaifi J.

BMC Cancer. 2011 May 22;11:189:1-7. doi: 10.1186/1471-2407-11-189.

12.

Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

Gebauer F, Tachezy M, Effenberger K, von Loga K, Zander H, Marx A, Kaifi JT, Sauter G, Izbicki JR, Bockhorn M.

J Surg Oncol. 2011 Aug 1;104(2):140-5. doi: 10.1002/jso.21957. Epub 2011 Apr 25.

PMID:
21520098
13.

L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.

Rawnaq T, Quaas A, Zander H, Gros SJ, Reichelt U, Blessmann M, Wilzcak W, Schachner M, Sauter G, Izbicki JR, Kaifi JT.

J Surg Res. 2012 Apr;173(2):314-9. doi: 10.1016/j.jss.2010.10.029. Epub 2010 Nov 21.

PMID:
21195422
14.

Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.

Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, Brandl S, Sauter G, Izbicki JR, Kaifi JT.

Ann Surg Oncol. 2011 Feb;18(2):559-65. doi: 10.1245/s10434-010-1191-0. Epub 2010 Jun 30.

PMID:
20589434
15.
16.

Biochemical characterization of the recombinant human Nogo-A ectodomain.

Zander H, Hettich E, Greiff K, Chatwell L, Skerra A.

FEBS J. 2007 May;274(10):2603-13. Epub 2007 Apr 16.

PMID:
17437522
17.

The healing of phenolized pulp exposures. 1949.

Zander HA, Glass RL.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Aug;100(2 Suppl):S97-101. No abstract available.

PMID:
16037796
18.

Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.

Breithaupt C, Schubart A, Zander H, Skerra A, Huber R, Linington C, Jacob U.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9446-51. Epub 2003 Jul 21.

19.

Characterization of GAPCenA, a GTPase activating protein for Rab6, part of which associates with the centrosome.

Cuif MH, Possmayer F, Zander H, Bordes N, Jollivet F, Couedel-Courteille A, Janoueix-Lerosey I, Langsley G, Bornens M, Goud B.

EMBO J. 1999 Apr 1;18(7):1772-82.

20.

[A combination of conventional single contrast arthrography with arthro-CT of the shoulder--an evaluation of 78 cases].

Will CH, Zander H, Chmielewski W, Koop H.

Aktuelle Radiol. 1993 Sep;3(5):309-12. German.

PMID:
8399420
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk